During the past decade, NYU Langone Medical Center - NYU Medical Oncology Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Langone Medical Center - NYU Medical Oncology Associates" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "NYU Langone Medical Center - NYU Medical Oncology Associates" are "Colorectal Cancer" (1 trials), "Gastric Cancer" (1 trials), "Gastroesophageal Junction Adenocarcinoma" (1 trials), "Glioblastoma" (1 trials) and "Lymphoma, Non-Hodgkin" (1 trials). Many other conditions were trialed in "NYU Langone Medical Center - NYU Medical Oncology Associates" in a lesser frequency.

Most popular intervention types in "NYU Langone Medical Center - NYU Medical Oncology Associates" are "Drug" (4 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "AB680" (1 trials), "Bendamustine" (1 trials), "Enzastaurin Hydrochloride" (1 trials), "Gemcitabine" (1 trials) and "Ibrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "NYU Langone Medical Center - NYU Medical Oncology Associates" are 4 trials for "All" genders.

Currently, there are NaN active trials in "NYU Langone Medical Center - NYU Medical Oncology Associates". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in NYU Langone Medical Center - NYU Medical Oncology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in NYU Langone Medical Center - NYU Medical Oncology Associates, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".